APA (7th ed.) Citation

H, S., R, K., M, H., K, N., M, F., Y, T., . . . J, T. (2026). BRCA1/2 Reversion Mutations in Japanese Patients with Metastatic Breast Cancer Progressing on Olaparib: OLIVE (WJOG15321B). Breast cancer (Tokyo, Japan), 33(3), 790. https://doi.org/10.1007/s12282-026-01855-2

Chicago Style (17th ed.) Citation

H, Sakai, et al. "BRCA1/2 Reversion Mutations in Japanese Patients with Metastatic Breast Cancer Progressing on Olaparib: OLIVE (WJOG15321B)." Breast Cancer (Tokyo, Japan) 33, no. 3 (2026): 790. https://doi.org/10.1007/s12282-026-01855-2.

MLA (9th ed.) Citation

H, Sakai, et al. "BRCA1/2 Reversion Mutations in Japanese Patients with Metastatic Breast Cancer Progressing on Olaparib: OLIVE (WJOG15321B)." Breast Cancer (Tokyo, Japan), vol. 33, no. 3, 2026, p. 790, https://doi.org/10.1007/s12282-026-01855-2.